Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 52
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Inflammopharmacology ; 31(5): 2685-2699, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37515653

RESUMO

Alzheimer's disease (AD) is a major neurological disease affecting elderly individuals worldwide. Existing drugs only reduce the symptoms of the disease without addressing the underlying causes. Commonly, Aß25-35 peptide aggregation is the main reason for AD development. Recently, the discovery of multiple protein-targeting molecules has provided a new strategy for treating AD. This study demonstrates the neuroprotective potential of oxymatrine against multiple mechanisms, such as acetylcholinesterase, mitochondrial damage, and ß-amyloid-induced cell toxicity. The in vitro cell culture studies showed that oxymatrine possesses significant potential to inhibit acetylcholine esterase and promotes antioxidant, antiapoptotic effects while preventing Aß25-35 peptide aggregation in PC12 cells. Furthermore, oxymatrine protects PC12 cells against Aß25-35-induced cytotoxicity and down-regulates the reactive oxygen species generation. The in vivo acute toxicological studies confirm the safety of oxymatrine without causing organ damage or death in animals. Overall, this study provided evidence that oxymatrine is an efficient neuroprotective agent, with a potential to be a multifunctional drug for Alzheimer's disease treatment. These findings present a reliable and synergistic approach for treating AD.


Assuntos
Doença de Alzheimer , Fármacos Neuroprotetores , Humanos , Ratos , Animais , Idoso , Peptídeos beta-Amiloides/metabolismo , Células PC12 , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/metabolismo , Acetilcolinesterase/farmacologia , Apoptose , Fragmentos de Peptídeos/toxicidade , Técnicas de Cultura de Células , Cognição , Fármacos Neuroprotetores/farmacologia , Fármacos Neuroprotetores/uso terapêutico
2.
Methods Mol Biol ; 2276: 305-324, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34060051

RESUMO

Specific bioenergetic signature reports on the current metabolic state of the cell, which may be affected by metabolic rearrangement, dysfunction or dysregulation of relevant signaling pathways, altered physiological condition or energy stress. A combined analysis of respiration , glycolytic flux, Krebs cycle activity, ATP levels, and total biomass allows informative initial assessment. Such simple, high-throughput, multiparametric methodology, called cell energy budget (CEB ) platform, is presented here and demonstrated with particular cell and tissue models. The CEB uses a commercial fluorescent lanthanide probe pH-Xtra™ to measure extracellular acidification (ECA) associated with lactate (L-ECA) and combined lactate/CO2 (T-ECA), a phosphorescent probe MitoXpress®-Xtra to measure oxygen consumption rate (OCR), a bioluminescent ATP kit, and an absorbance-based total protein assay. All the assays are performed on a standard multi-label reader. Using the same readouts, the CEB approach can be extended to more detailed mechanistic studies, by targeting specific pathways in cell bioenergetics and measuring other cellular parameters, such as NAD(P)H, Ca2+, mitochondrial pH, membrane potential, redox state, with conventional fluorescent or luminescent probes.


Assuntos
Trifosfato de Adenosina/metabolismo , Dióxido de Carbono/metabolismo , Células/metabolismo , Ensaios de Triagem em Larga Escala/métodos , Ácido Láctico/metabolismo , Animais , Metabolismo Energético , Espaço Extracelular/química , Espaço Extracelular/metabolismo , Corantes Fluorescentes/química , Concentração de Íons de Hidrogênio , Consumo de Oxigênio/fisiologia , Células PC12 , Ratos
3.
Environ Toxicol ; 35(12): 1326-1333, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32662595

RESUMO

Organophosphate flame retardants (OPFRs) have become a growing concern due to their potential environmental and health risk. However, limited studies have described the toxicity, particularly neurotoxicity of alkyl and aromatic OPFRs. This study investigated the neurotoxicity of alkyl tri-n-butyl phosphate (TnBP) and aromatic tricresyl phosphate (TCP) to rat adrenal pheochromocytoma (PC12) cells for 24 h. Viability detection showed dose-response toxicity effect of TCP and TnBP to PC12 cells. The half-maximal inhibitory concentration of 24 h (24 h-IC50 ) of TCP and TnBP were 2415.61 and 338.09 µM, respectively. Both TnBP and TCP significantly changed the acetylcholinesterase (AChE) activity, and TnBP is more likely to cause neurotoxicity to PC12 cells compared to TCP. Also, The results of LDH and caspase-3 activity detection as well as Hoechst staining suggested that cell apoptosis induced by TCP and TnBP may be the primary pathway. These findings provide a toxicity data of aromatic and alkyl-substituted OPFRs to PC12 cells, and a new insight into the toxicity of OPFRs on health risk assessment.


Assuntos
Apoptose/efeitos dos fármacos , Retardadores de Chama/toxicidade , Neurônios/efeitos dos fármacos , Organofosfatos/toxicidade , Tritolil Fosfatos/toxicidade , Acetilcolinesterase/metabolismo , Animais , Caspase 3/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Neurônios/enzimologia , Neurônios/patologia , Células PC12 , Ratos
4.
Biochimie ; 176: 31-44, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32585227

RESUMO

Nerve growth factor (NGF) is a minor and neglected component of snake venom. Present study describes the purification and characterization of a NGF isoform (RVV-NGFa) from Indian Russell's viper venom (RVV). RVV-NGFa showed a protonated molecular ion [MH+] at m/z 17388.725 Da. The RVV-NGFa induced neuritogenesis in PC-12 cells but did not show cytotoxicity in mammalian cells, hemolytic activity, platelet modulation, and interference in blood coagulation system which are the characteristic pharmacological properties of RVV. By ELISA and immunofluorescence microplate reader assay, the RVV-NGFa showed appreciable binding to TrkA receptor expressed in breast cancer MDA-MB-231 and MCF-7 cells; nevertheless, pre-incubation of cells with anti-TrkA (and not TrkB or TrkC) or anti-p75NTR antibody significantly decreased (p < 0.05) this binding. The RVV-NGFa demonstrated insignificant binding with non-cancerous cells (HEK-293, L6) lacking TrkA receptor. The binding of RVV-NGFa to TrkA receptor of breast cancer cells resulted in internalization of ligand (RVV-NGFa)-receptor (TrkA) complex to cell cytoplasm in a time-dependent manner. The spectrofluorometric study demonstrated an interaction between RVV-NGFa and cytosolic domain of the purified TrkA receptor. The fluorescence (FITC)-tagged RVV-NGFa depicted a strong fluorescence signal that was observed under a fluorescence microscope and determined by fluorescence microplate reader assay post binding to breast cancer cells; but no fluorescence signal was detected after incubating FITC-RVV-NGFa with non-cancerous L6 and HEK-293 cells. The clinical application of FITC/fluorescence nanoparticle tagged RVV-NGFa for the ex vivo and in vivo diagnosis of breast cancer is highly promising.


Assuntos
Neoplasias da Mama , Regulação Enzimológica da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Nanopartículas , Proteínas de Neoplasias/biossíntese , Fator de Crescimento Neural , Imagem Óptica , Receptor trkA/biossíntese , Venenos de Víboras , Animais , Neoplasias da Mama/diagnóstico por imagem , Neoplasias da Mama/enzimologia , Feminino , Fluoresceína-5-Isotiocianato/química , Fluoresceína-5-Isotiocianato/farmacologia , Células HEK293 , Humanos , Células MCF-7 , Fator de Crescimento Neural/química , Fator de Crescimento Neural/farmacologia , Células PC12 , Ratos , Coloração e Rotulagem , Venenos de Víboras/química , Venenos de Víboras/farmacologia
5.
Artigo em Inglês | MEDLINE | ID: mdl-31343137

RESUMO

BACKGROUND: Carbohydrate metabolism disturbances have long been considered the cause of civilisation diseases, such as type 2 diabetes, obesity, or cardiovascular diseases. Currently an increasing number of theses also link impaired glucose and/or insulin metabolism to neurodegenerative diseases, calling them neurometabolic diseases. AIM OF THE STUDY: Aim of the study was to assess the cytotoxic influence of multicompound biological material (blood serum) from people with different carbohydrate metabolism disturbances to the viability of PC12 cell line. MATERIAL AND METHODS: Undifferentiated PC12 cell line were incubated for 48 hours in standard conditions with the addition of human serum from individuals with diffrent (low and high) levels of hyperglycaemia (LGL and HGL) and hyperinsulinaemia (LIL and HIL). The cytotoxicity was estimated by the MTT test, and the viability percentage (SP%) was calculated in relation to control samples (cells incubated only with RPMI). RESULTS: The obtained results indicate cytotoxic activity and decreased viability of the PC12 cells after 48 hours of incubation with human serum with different degrees of hyperglycaemia and insulinaemia. Cell viability increased slightly with the increase in glucose level but decreased with the increase in insulin concentration in individual groups, but without statistical significance. CONCLUSIONS: Blood serum, as multicompound biological material, influences negatively PC12 cell line but in a variety of ways. Increasing hyperinsulinaemia has a higher cytotoxic effect on the cells than hyperglycaemia, which probably results from the fact that it is compensated by other components of biological material; however, further studies are necessary to obtain more detailed characteristics of these processes.


Assuntos
Hiperglicemia , Hiperinsulinismo , Modelos Biológicos , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Glicemia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Células PC12 , Ratos
6.
Brain Res ; 1714: 8-17, 2019 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-30779912

RESUMO

The disruption of appropriate cellular stress responses is implicated in the pathogenesis of different neurological disorders including ischemic injury. Early diagnosis and treatment are often associated with better prognosis in ischemic stroke patients. Thus, there is an urgent need to improve the speed and accuracy of stroke diagnosis by developing highly sensitive stroke biomarkers. We recently reported that transfer RNA (tRNA) was involved in cell stress response pathways. Under cell stress conditions, mature tRNA is cleaved by a specific ribonuclease, angiogenin, generating tRNA-derived stress-induced RNA (tiRNA). To study tiRNA generation in an in vitro model of ischemic-reperfusion injury, we used the rat neuronal cell line, PC12, in combination with analysis of SYBR staining and immuno-northern blotting using anti-1-methyladenosine antibody, which detects 1-methyladenosine (m1A) modification of tRNA. We demonstrated that oxygen-glucose deprivation induced tRNA cleavage and tiRNA generation. Time course analysis showed a dramatic up-regulation of tiRNA generation by oxygen-glucose deprivation (OGD) which started a few minutes after reperfusion. Minocycline, a neuroprotective antibiotic, treatment protected PC12 cells against OGD-reperfusion cell damage resulting in a marked down-regulation of the generated tiRNA. Our findings show that cleavage of tRNA and tiRNA generation in rat neuronal PC12 cells occurs with reperfusion injury and the detection of tiRNA could be used as a potential cell damage marker and treatment effect indicator for this type of injury.


Assuntos
RNA de Transferência/genética , Traumatismo por Reperfusão/genética , Estresse Fisiológico/genética , Adenosina/análogos & derivados , Adenosina/metabolismo , Animais , Biomarcadores , Sobrevivência Celular/efeitos dos fármacos , Glucose/metabolismo , Hipóxia/metabolismo , Isquemia/genética , Isquemia/metabolismo , Neurônios/metabolismo , Oxigênio/metabolismo , Células PC12 , RNA de Transferência/metabolismo , Ratos , Traumatismo por Reperfusão/metabolismo , Ribonuclease Pancreático/metabolismo , Acidente Vascular Cerebral/diagnóstico
7.
Regul Toxicol Pharmacol ; 101: 12-23, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30359698

RESUMO

The application of toxic equivalency factors (TEFs) or toxic units to estimate toxic potencies for mixtures of chemicals which contribute to a biological effect through a common mechanism is one approach for filling data gaps. Toxic Equivalents (TEQ) have been used to express the toxicity of dioxin-like compounds (i.e., dioxins, furans, and dioxin-like polychlorinated biphenyls (PCBs)) in terms of the most toxic form of dioxin: 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD). This study sought to integrate two data gap filling techniques, quantitative structure-activity relationships (QSARs) and TEFs, to predict neurotoxicity TEQs for PCBs. Simon et al. (2007) previously derived neurotoxic equivalent (NEQ) values for a dataset of 87 PCB congeners, of which 83 congeners had experimental data. These data were taken from a set of four different studies measuring different effects related to neurotoxicity, each of which tested overlapping subsets of the 83 PCB congeners. The goals of the current study were to: (i) evaluate an alternative neurotoxic equivalent factor (NEF) derivations from an expanded dataset, relative to those derived by Simon et al. and (ii) develop QSAR models to provide NEF estimates for the large number of untested PCB congeners. The models used multiple linear regression, support vector regression, k-nearest neighbor and random forest algorithms within a 5-fold cross validation scheme and position-specific chlorine substitution patterns on the biphenyl scaffold as descriptors. Alternative NEF values were derived but the resulting QSAR models had relatively low predictivity (RMSE ∼0.24). This was mostly driven by the large uncertainties in the underlying data and NEF values. The derived NEFs and the QSAR predicted NEFs to fill data gaps should be applied with caution.


Assuntos
Poluentes Ambientais/toxicidade , Síndromes Neurotóxicas , Bifenilos Policlorados/toxicidade , Animais , Encéfalo/metabolismo , Cálcio/metabolismo , Dopamina/metabolismo , Poluentes Ambientais/química , Células PC12 , Bifenilos Policlorados/química , Proteína Quinase C/metabolismo , Relação Quantitativa Estrutura-Atividade , Ratos , Medição de Risco , Canal de Liberação de Cálcio do Receptor de Rianodina/metabolismo
8.
J Pharm Pharmacol ; 70(11): 1553-1560, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30159909

RESUMO

OBJECTIVES: Reported antioxidant, anti-inflammatory and neuroprotective properties for one aqueous-ethanolic extract from Thalassia testudinum which grows in the Caribbean Sea compelled us to explore about extract cytotoxic effects. METHODS: Cell viability was assayed on tumour (HepG2, PC12, Caco-2 and 4T1) and non-tumour (VERO, 3T3, CHO, MCDK and BHK2) cell lines. The extract effects upon primary cultures of rat and human hepatocytes and human lymphocytes were assayed. KEY FINDINGS: The extract exhibited cytotoxicity against cancer cells compared to normal cells, and the IC50 values were 102 µg/ml for HepG2, 135 µg/ml for PC12, 165 µg/ml for Caco-2 and 129 µg/ml for 4T1 cells after 48 h, whereas IC50 could not be calculated for normal cells. Additional data from a high-content screening multiparametric assay indicated that after 24-h exposure, the extract (up to 100 µg/ml) induced death in HepG2 cells through oxidative stress-associated mechanism, DNA damage and hypercalcaemia. Comet assay corroborated extract-induced DNA damage. CONCLUSIONS: Thalassia testudinum extract is more cytotoxic and produced more DNA damage on human hepatoma cells than to other non-tumour cells. A possible mechanism is suggested for extract-induced cytotoxicity based on oxidative stress, nuclear damage and hypercalcaemia in HepG2 cells. T. testudinum may be a source for antitumour agents.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Etanol/química , Neoplasias/tratamento farmacológico , Extratos Vegetais/farmacologia , Solventes/química , Água/química , Adulto , Animais , Antineoplásicos Fitogênicos/isolamento & purificação , Antineoplásicos Fitogênicos/toxicidade , Células CACO-2 , Região do Caribe , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Células Hep G2 , Humanos , Hydrocharitaceae , Concentração Inibidora 50 , Linfócitos/efeitos dos fármacos , Linfócitos/patologia , Masculino , Neoplasias/patologia , Células PC12 , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/toxicidade , Cultura Primária de Células , Ratos , Ratos Sprague-Dawley
9.
Sci Rep ; 8(1): 8669, 2018 06 06.
Artigo em Inglês | MEDLINE | ID: mdl-29875468

RESUMO

Nerve regeneration is a serious clinical challenge following peripheral nerve injury. Lycium barbarum polysaccharide (LBP) is the major component of wolfberry extract, which has been shown to be neuroprotective and promising in nerve recovery in many studies. Electrospun nanofibers, especially core-shell structured nanofibers being capable of serving as both drug delivery system and tissue engineering scaffolds, are well known to be suitable scaffolds for regeneration of peripheral nerve applications. In this study, LBP was incorporated into core-shell structured nanofibrous scaffolds via coaxial electrospinning. Alamar blue assays were performed to investigate the proliferation of both PC12 and Schwann cells cultured on the scaffolds. The neuronal differentiation of PC12 cells was evaluated by NF200 expression with immunostaining and morphology changes observed by SEM. The results indicated that the released LBP dramatically enhanced both proliferation and neuronal differentiation of PC12 cells induced by NGF. Additionally, the promotion of Schwann cells myelination and neurite outgrowth of DRG neurons were also observed on LBP loaded scaffolds by LSCM with immunostaining. In summary, LBP, as a drug with neuroprotection, encapsulated into electrospun nanofibers could be a potential candidate as tissue engineered scaffold for peripheral nerve regeneration.


Assuntos
Portadores de Fármacos/química , Medicamentos de Ervas Chinesas/administração & dosagem , Nanofibras/química , Neurogênese/efeitos dos fármacos , Fármacos Neuroprotetores/administração & dosagem , Copolímero de Ácido Poliláctico e Ácido Poliglicólico/química , Alicerces Teciduais/química , Animais , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Medicamentos de Ervas Chinesas/farmacologia , Nanofibras/ultraestrutura , Regeneração Nervosa/efeitos dos fármacos , Crescimento Neuronal/efeitos dos fármacos , Neurônios/citologia , Neurônios/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Células PC12 , Ratos , Células de Schwann/citologia , Células de Schwann/efeitos dos fármacos , Engenharia Tecidual
10.
Biotechniques ; 63(6): 267-274, 2017 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-29235973

RESUMO

Cell migration, which is central to a wide variety of life processes, involves integration of the extracellular matrix (ECM) with the internal cytoskeleton and motor proteins via receptors spanning the plasma membrane. Cell migration can be induced by a variety of signals, including gradients of external soluble molecules, differences in ECM composition, or electrical gradients. Current in vitro methods to study cell migration only test one substrate at a time. Here, we present a method for assessing cell adhesion, migration, and differentiation in up to 20 different test conditions simultaneously, using only minute amounts of target substrate. Our system, which we call the linear array of multi-substrate cell migration assay (LAMA), has two configurations for direct comparison of one or two cell types in response to an array of ECM constituents under the same culture conditions. This culture model utilizes only nanogram amounts of test substrates and a minimal number of cells, which maximizes the use of limited and expensive test reagents. Moreover, LAMA can also be used for high-throughput screening of potential pharmaceuticals that target ECM-dependent cell behavior and differentiation.


Assuntos
Fenômenos Fisiológicos Celulares/fisiologia , Técnicas Citológicas/métodos , Matriz Extracelular/metabolismo , Animais , Linhagem Celular , Embrião de Galinha , Células-Tronco Embrionárias/citologia , Matriz Extracelular/química , Células PC12 , Ratos
11.
Chemosphere ; 183: 353-360, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28554019

RESUMO

Tris (1,3-dichloro-2-propyl) phosphate (TDCIPP), one of the most universally used organophosphate flame retardants (OPFRs), is an environmental pollutant. However, limited information is available regarding its toxicity and environmental health risk. In the present study, PC12 cells provided a useful model for the evaluation of the toxic effects of TDCIPP. Exposure to 7.5, 15, 30, or 60 µM TDCIPP for 72 h inhibited cell viability, and enhanced cellular apoptosis and oxidative stress. To further explore the underlying mechanisms, digital gene expression (DGE) technology was used to identify early transcriptional changes following TDCIPP exposure. Expression of the transcripts of 161 genes was significantly altered upon treatment with TDCIPP. Functional and pathway analysis of the transcriptional profile demonstrated that genes showing significant TDCIPP-associated changes in expression were involved in the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway, extracellular matrix-receptor interactions, protein digestion and absorption, and microRNAs in cancer. Using quantitative real-time PCR, we validated the differential expression of selected genes. These results showed that the expression profiles of cells exposed to 60 µM TDCIPP were consistent with the DGE data. Furthermore, western blotting showed that treatment with TDCIPP reduced the Bcl-2/Bax ratio and attenuated PI3K/Akt/Myc signaling. Taken together, these data suggest that TDCIPP exposure can reduce cell viability and induce apoptosis in PC12 cells by inhibiting activation of the PI3K/Akt/Myc signaling pathway. These observations provide valuable preliminary information regarding the mechanisms of TDCIPP-induced toxicity in PC12 cells and indicate that further study of the toxicity of other environmental OPFRs is warranted.


Assuntos
Poluentes Ambientais/toxicidade , Retardadores de Chama/toxicidade , Organofosfatos/toxicidade , Animais , Apoptose/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Poluentes Ambientais/análise , Perfilação da Expressão Gênica , Estresse Oxidativo/efeitos dos fármacos , Células PC12 , Fosfatos/farmacologia , Ratos , Transdução de Sinais/efeitos dos fármacos
12.
Toxicol Appl Pharmacol ; 325: 61-70, 2017 06 15.
Artigo em Inglês | MEDLINE | ID: mdl-28396216

RESUMO

Estrogen receptors (ERs) α and ß are distributed in most tissues of women and men. ERs are bound by estradiol (E2), a natural hormone, and mediate the pleiotropic and tissue-specific effects of E2, such as proliferation of breast epithelial cells or protection and differentiation of neuronal cells. Numerous environmental molecules, called endocrine disrupting compounds, also interact with ERs. Phytoestrogens belong to this large family and are considered potent therapeutic molecules that act through their selective estrogen receptor modulator (SERM) activity. Using breast cancer cell lines as a model of estrogen-dependent proliferation and a stably ER-expressing PC12 cell line as a model of neuronal differentiating cells, we studied the SERM activity of major dietary compounds, such as apigenin, liquiritigenin, daidzein, genistein, coumestrol, resveratrol and zearalenone. The ability of these compounds to induce ER-transactivation and breast cancer cell proliferation and enhance Nerve Growth Factor (NGF) -induced neuritogenesis was assessed. Surprisingly, although all compounds were able to activate the ER through an estrogen responsive element reporter gene, they showed differential activity toward proliferation or differentiation. Apigenin and resveratrol showed a partial or no proliferative effect on breast cancer cells but fully contributed to the neuritogenesis effect of NGF. However, daidzein and zearalenone showed full effects on cellular proliferation but did not induce cellular differentiation. In summary, our results suggest that the therapeutic potential of phytoestrogens can diverge depending on the molecule and the phenotype considered. Hence, apigenin and resveratrol might be used in the development of therapeutics for breast cancer and brain diseases.


Assuntos
Neoplasias das Glândulas Suprarrenais/tratamento farmacológico , Antineoplásicos Fitogênicos/farmacologia , Neoplasias da Mama/tratamento farmacológico , Proliferação de Células/efeitos dos fármacos , Dieta , Neurogênese/efeitos dos fármacos , Feocromocitoma/tratamento farmacológico , Fitoestrógenos/farmacologia , Moduladores Seletivos de Receptor Estrogênico/farmacologia , Neoplasias das Glândulas Suprarrenais/genética , Neoplasias das Glândulas Suprarrenais/metabolismo , Neoplasias das Glândulas Suprarrenais/patologia , Animais , Apigenina/farmacologia , Neoplasias da Mama/genética , Neoplasias da Mama/metabolismo , Neoplasias da Mama/patologia , Quimiocina CXCL12/genética , Quimiocina CXCL12/metabolismo , Relação Dose-Resposta a Droga , Receptor alfa de Estrogênio/efeitos dos fármacos , Receptor alfa de Estrogênio/genética , Receptor alfa de Estrogênio/metabolismo , Feminino , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Isoflavonas/farmacologia , Células MCF-7 , Proteínas do Tecido Nervoso/metabolismo , Neuritos/efeitos dos fármacos , Neuritos/metabolismo , Neuritos/patologia , Células PC12 , Feocromocitoma/genética , Feocromocitoma/metabolismo , Feocromocitoma/patologia , Ratos , Elementos de Resposta , Resveratrol , Estilbenos/farmacologia , Transcrição Gênica/efeitos dos fármacos , Transfecção , Zearalenona/farmacologia
13.
Biomed Environ Sci ; 30(12): 927-931, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29335064

RESUMO

Little information is available about the effects of exposure to pulsed microwaves on neuronal Ca2+ signaling under non-thermal conditions. In this study, rat pheochromocytoma (PC12) cells were exposed to pulsed microwaves for 6 min at a specific absorption rate (SAR) of 4 W/kg to assess possible real-time effects. During microwave exposure, free calcium dynamics in the cytosol, mitochondria, and nucleus of cells were monitored by time-lapse microfluorimetry using a genetically encoded calcium indicator (ratiometric-pericam, ratiometric-pericam-mt, and ratiometric-pericam-nu). We established a waveguide-based real-time microwave exposure system under accurately controlled environmental and dosimetric conditions and found no significant changes in the cytosolic, mitochondrial, or nuclear calcium levels in PC12 cells. These findings suggest that no dynamic changes occurred in [Ca2+]c, [Ca2+]m, or [Ca2+]n of PC12 cells at the non-thermal level.


Assuntos
Cálcio/metabolismo , Núcleo Celular/efeitos da radiação , Citosol/efeitos da radiação , Micro-Ondas , Mitocôndrias/efeitos da radiação , Animais , Núcleo Celular/metabolismo , Citosol/metabolismo , Microscopia Confocal , Mitocôndrias/metabolismo , Células PC12 , Ratos
14.
ACS Appl Mater Interfaces ; 8(9): 5804-12, 2016 Mar 09.
Artigo em Inglês | MEDLINE | ID: mdl-26860350

RESUMO

The traditional in vitro nanotoxicity assessment approaches are conducted on a monolayer of cell culture. However, to study a cell response without interference from the neighbor cells, a single cell study is necessary; especially in cases of neuronal, cancerous, and stem cells, wherein an individual cell's fate is often not explained by the whole cell population. Nonetheless, a single cell does not mimic the actual in vivo environment and lacks important information regarding cell communication with its microenvironment. Both a single cell and a cell population provide important and complementary information about cells' behaviors. In this research, we explored nanotoxicity assessment on a single cell and a small cell population using electrochemical impedance spectroscopy and a microelectromechanical system (MEMS) device. We demonstrated a controlled capture of PC12 cells in different-sized microwells (to capture a different number of cells) using a combined method of surface functionalization and dielectrophoresis. The present approach provides a rapid nanotoxicity response as compared to other conventional approaches. This is the first study, to our knowledge, which demonstrates a comparative response of a single cell and small cell colonies on the same MEMS platform, when exposed to metaloxide nanoparticles. We demonstrated that the microenvironment of a cell is also accountable for cells' behaviors and their responses to nanomaterials. The results of this experimental study open up a new hypothesis to be tested for identifying the role of cell communication in spreading toxicity in a cell population.


Assuntos
Espectroscopia Dielétrica , Nanopartículas/química , Animais , Sobrevivência Celular/efeitos dos fármacos , Cobre/química , Eletrodos , Nanopartículas Metálicas/química , Nanopartículas Metálicas/toxicidade , Sistemas Microeletromecânicos , Nanopartículas/toxicidade , Células PC12 , Ratos , Compostos de Estanho/química , Titânio/química , Testes de Toxicidade
15.
Neurotox Res ; 28(4): 302-18, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26201265

RESUMO

Oxidative stress has been strongly implicated in the progression of Parkinson's disease (PD). Depletion of cytoplasmic glutathione levels is one of the indications of oxidative stress, which occur in the substantia nigra of PD patients at an early stage of the disease process. It has been shown that glutathione depletion causes the inhibition of mitochondrial complex I, thus affecting mitochondrial function leading to oxidative stress via production of reactive oxygen species. Studies were carried out to investigate the role of D-512, a potent multifunctional neuroprotective D2/D3 receptor agonist, in protecting dopaminergic PC12 cells treated with buthionine sulfoximine (BSO), an inhibitor of key enzyme in glutathione synthesis and 6-hydroxydopamine (6-OHDA), a widely used neurotoxin. D-512 was able to restore level of glutathione against BSO/6-OHDA-mediated glutathione depletion. D-512 also showed significant neuroprotection in PC12 cells against toxicity induced by combined treatment of BSO and 6-OHDA. Furthermore, D-512 was able to restore both phospho-extracellular signal-regulated kinase and phospho-Jun N-terminal kinase levels upon treatment with 6-OHDA providing an evidence on the possible mechanism of action for neuroprotection by modulating mitogen-activated protein kinases. We have further demonstrated the neuroprotective effects of D-512 against oxidative insult produced by BSO and 6-OHDA in PC12 cells.


Assuntos
Agonistas de Dopamina/farmacologia , Glutationa/metabolismo , Indóis/farmacologia , Fármacos Neuroprotetores/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Doença de Parkinson/metabolismo , Tiazóis/farmacologia , Animais , Caspases/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Neurônios Dopaminérgicos/efeitos dos fármacos , Neurônios Dopaminérgicos/metabolismo , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Glutamato-Cisteína Ligase/metabolismo , Glutationa/análise , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Oxidopamina/toxicidade , Células PC12 , Ratos , Transdução de Sinais/efeitos dos fármacos
16.
J Mol Med (Berl) ; 93(11): 1247-55, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26070438

RESUMO

UNLABELLED: The presence of germline mutations affecting the MYC-associated protein X (MAX) gene has recently been identified as one of the now 11 major genetic predisposition factors for the development of hereditary pheochromocytoma and/or paraganglioma. Little is known regarding how missense variants of unknown significance (VUS) in MAX affect its pivotal role in the regulation of the MYC/MAX/MXD axis. In the present study, we propose a consensus computational prediction based on five "state-of-the-art" algorithms. We also describe a PC12-based functional assay to assess the effects that 12 MAX VUS may have on MYC's E-box transcriptional activation. For all but two of these 12 VUS, the functional assay and the consensus computational prediction gave consistent results; we classified seven variants as pathogenic and three as nonpathogenic. The introduction of wild-type MAX cDNA into PC12 cells significantly decreased MYC's ability to bind to canonical E-boxes, while pathogenic MAX proteins were not able to fully repress MYC activity. Further clinical and molecular evaluation of variant carriers corroborated the results obtained with our functional assessment. In the absence of clear heritability, clinical information, and molecular data, consensus computational predictions and functional models are able to correctly classify VUS affecting MAX. KEY MESSAGES: A functional assay assesses the effects of MAX VUS over MYC transcriptional activity. A consensus computational prediction and the functional assay show high concordance. Variant carriers' clinical and molecular data support the functional assessment.


Assuntos
Neoplasias das Glândulas Suprarrenais/genética , Algoritmos , Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos/genética , Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos/metabolismo , Fatores de Transcrição de Zíper de Leucina Básica/genética , Fatores de Transcrição de Zíper de Leucina Básica/metabolismo , Paraganglioma/genética , Feocromocitoma/genética , Sequência de Aminoácidos , Animais , Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos/química , Fatores de Transcrição de Zíper de Leucina Básica/química , Simulação por Computador , Elementos E-Box , Mutação em Linhagem Germinativa , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Mutação de Sentido Incorreto , Células PC12 , Ratos
17.
PLoS One ; 10(6): e0128601, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26047500

RESUMO

Traumatic Brain Injury (TBI) is the result of a mechanical impact on the brain provoking mild, moderate or severe symptoms. It is acknowledged that TBI leads to apoptotic and necrotic cell death; however, the exact mechanism by which brain trauma leads to neural injury is not fully elucidated. Some studies have highlighted the pivotal role of the Kallikrein-Kinin System (KKS) in brain trauma but the results are still controversial and inconclusive. In this study, we investigated both the expression and the role of Bradykinin 1 and 2 receptors (B1R and B2R), in mediating neuronal injury under chemical neurotoxicity paradigm in PC12 cell lines. The neuronal cell line PC12 was treated with the apoptotic drug Staurosporine (STS) to induce cell death. Intracellular calcium release was evaluated by Fluo 4-AM staining and showed that inhibition of the B2R prevented calcium release following STS treatment. Differential analyses utilizing immunofluorescence, Western blot and Real-time Polymerase Chain Reaction revealed an upregulation of both bradykinin receptors occurring at 3h and 12h post-STS treatment, but with a higher induction of B2R compared to B1R. This implies that STS-mediated apoptosis in PC12 cells is mainly conducted through B2R and partly via B1R. Finally, a neuroproteomics approach was conducted to find relevant proteins associated to STS and KKS in PC12 cells. Neuroproteomics results confirmed the presence of an inflammatory response leading to cell death during apoptosis-mediated STS treatment; however, a "survival" capacity was shown following inhibition of B2R coupled with STS treatment. Our data suggest that B2R is a key player in the inflammatory pathway following STS-mediated apoptosis in PC12 cells and its inhibition may represent a potential therapeutic tool in TBI.


Assuntos
Inibidores Enzimáticos/toxicidade , Sistema Calicreína-Cinina/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Neurônios/patologia , Estaurosporina/toxicidade , Animais , Morte Celular/efeitos dos fármacos , Neurônios/imunologia , Neurônios/metabolismo , Células PC12 , Proteômica , Ratos , Receptor B1 da Bradicinina/análise , Receptor B1 da Bradicinina/genética , Receptor B1 da Bradicinina/imunologia , Receptor B2 da Bradicinina/análise , Receptor B2 da Bradicinina/genética , Receptor B2 da Bradicinina/imunologia , Transdução de Sinais/efeitos dos fármacos , Ativação Transcricional
18.
J Vis Exp ; (97)2015 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-25867757

RESUMO

Red/near-infrared light therapy (R/NIR-LT), delivered by laser or light emitting diode (LED), improves functional and morphological outcomes in a range of central nervous system injuries in vivo, possibly by reducing oxidative stress. However, effects of R/NIR-LT on oxidative stress have been shown to vary depending on wavelength or intensity of irradiation. Studies comparing treatment parameters are lacking, due to absence of commercially available devices that deliver multiple wavelengths or intensities, suitable for high through-put in vitro optimization studies. This protocol describes a technique for delivery of light at a range of wavelengths and intensities to optimize therapeutic doses required for a given injury model. We hypothesized that a method of delivering light, in which wavelength and intensity parameters could easily be altered, could facilitate determination of an optimal dose of R/NIR-LT for reducing reactive oxygen species (ROS) in vitro. Non-coherent Xenon light was filtered through narrow-band interference filters to deliver varying wavelengths (center wavelengths of 440, 550, 670 and 810 nm) and fluences (8.5x10(-3) to 3.8x10(-1) J/cm2) of light to cultured cells. Light output from the apparatus was calibrated to emit therapeutically relevant, equal quantal doses of light at each wavelength. Reactive species were detected in glutamate stressed cells treated with the light, using DCFH-DA and H2O2 sensitive fluorescent dyes. We successfully delivered light at a range of physiologically and therapeutically relevant wavelengths and intensities, to cultured cells exposed to glutamate as a model of CNS injury. While the fluences of R/NIR-LT used in the current study did not exert an effect on ROS generated by the cultured cells, the method of light delivery is applicable to other systems including isolated mitochondria or more physiologically relevant organotypic slice culture models, and could be used to assess effects on a range of outcome measures of oxidative metabolism.


Assuntos
Estresse Oxidativo/efeitos da radiação , Fototerapia/métodos , Animais , Células Cultivadas , Raios Infravermelhos , Lasers , Mitocôndrias/metabolismo , Mitocôndrias/efeitos da radiação , Oxirredução , Estresse Oxidativo/fisiologia , Células PC12 , Ratos , Espécies Reativas de Oxigênio/metabolismo , Retina/citologia , Retina/efeitos da radiação , Xenônio/química
19.
Methods Mol Biol ; 1265: 333-48, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25634285

RESUMO

Changes in bioenergetic parameters report on metabolic rearrangement, dysfunction of major pathways, and regulatory processes within the cell, adaptation to energy stress, or new physiological condition. A combined measurement of oxidative phosphorylation, glycolytic flux, the Krebs cycle activity, ATP levels, and total biomass allows detailed metabolic assessment. We describe a simple methodology for high-throughput multiparametric assessment of cell bioenergetics, called cell energy budget (CEB) platform, and demonstrate its practical use with cell models. The CEB relies on a standard multi-label reader with time-resolved fluorescence capabilities, the lanthanide probe pH-Xtra™ to measure extracellular acidification (ECA) associated with lactate (L-ECA) and combined lactate/CO2 (T-ECA) extrusion, the phosphorescent probe MitoXpress®-Xtra to measure oxygen consumption rate (OCR), the bioluminescent total ATP assay, and absorbance-based total protein assay. This approach can be further extended with the measurement of other cellular parameters, such as NAD(P)H, Ca(2+), mitochondrial pH, membrane potential, and redox state, using the corresponding fluorescent or luminescent probes.


Assuntos
Metabolismo Energético , Ensaios de Triagem em Larga Escala , Animais , Glicólise , Ensaios de Triagem em Larga Escala/métodos , Medições Luminescentes/métodos , Fosforilação Oxidativa , Consumo de Oxigênio , Células PC12 , Ratos
20.
Eur J Med Chem ; 89: 296-303, 2015 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-25462245

RESUMO

A new series of tacrine-based acetylcholinesterase (AChE) inhibitors 7a-l were designed by replacing the benzene ring of tacrine with aryl-dihydropyrano[2,3-c]pyrazole. The poly-functionalized hybrid molecules 7a-l were efficiently synthesized through multi-component reaction and subsequent Friedländer reaction between the obtained pyrano[2,3-c]pyrazoles and cyclohexanone. Most of target compounds showed potent and selective anti-AChE activity at sub-micromolar range. The most potent compound 7h bearing a 3,4-dimethoxyphenyl group was more active than reference drug tacrine. The representative compound 7h could significantly protect neurons against oxidative stress as potent as quercetin at low concentrations. The docking study of compound 7h with AChE enzyme revealed that the (R)-enantiomer binds preferably to CAS while the (S)-enantiomer prone to be a PAS binder.


Assuntos
Inibidores da Colinesterase/síntese química , Compostos Heterocíclicos de 4 ou mais Anéis/síntese química , Fármacos Neuroprotetores/síntese química , Piranos/química , Pirazóis/química , Tacrina/análogos & derivados , Tacrina/síntese química , Animais , Butirilcolinesterase/sangue , Morte Celular/efeitos dos fármacos , Inibidores da Colinesterase/química , Inibidores da Colinesterase/farmacologia , Desenho de Fármacos , Electrophorus , Compostos Heterocíclicos de 4 ou mais Anéis/química , Compostos Heterocíclicos de 4 ou mais Anéis/farmacologia , Cavalos , Peróxido de Hidrogênio/farmacologia , Cinética , Simulação de Acoplamento Molecular , Fármacos Neuroprotetores/química , Fármacos Neuroprotetores/farmacologia , Células PC12 , Ratos , Tacrina/química , Tacrina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA